跳至主要内容
临床试验/NCT07677657
NCT07677657尚未招募不适用

Deepview HHF Training and Validation Label Expansion Study

SpectralMD0 个研究点目标入组 280 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
280
主要终点
Label Expansion Through Imaging HHF

研究概览

简要总结

The purpose of this Study is to help expand the use of the DeepView AI System so that it can assess burn injuries on the hands, head/face, and feet. To do this, the Study will collect new images of burns in these areas. Some of these images will be used to improve and retrain the AI system, while others will be used to test how well the updated system performs. The images for both purposes will be collected at the same time. The new images from the hands, head/face, and feet will then be combined with existing images from other body areas. This will allow researchers to determine whether the updated AI system performs as well as, or better than, previous versions of the technology. For participants with Study Burns requiring surgical excision, the Study site clinician will collect punch biopsies from the Study Burn according to a standardised burn wound punch biopsy collection.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Willing and able to give informed consent, have a witnessed verbal consent, family discussion if intubated and retrospective consent for those that are intubated
  • Life expectancy > 1 month
  • Thermal burn mechanism (flame, scald, or contact)
  • The Study Burn(s) occurred less than 72 hours prior to the time of first imaging
  • Minimum burn wound size for adult or paediatric participants is 0.25% TBSA per region
  • Have burn(s) on the head, hands and/or feet that meet the criteria for a Study Burn. If multiple regions meet the Study Burn criteria, per the discretion of the Investigator, all Study Burn regions should be included.

排除标准

  • Sepsis at the time of enrolment
  • Infection of the burn wound at the time of enrolment
  • Immunosuppression / radiation / chemotherapy < 3 months prior to enrolment
  • Concurrent use of investigational products with a known effect on the burn sites; and/or imaging
  • Concurrent use of products such as chemical debriding agents, skin substitutes and others that the principal investigator deems will have an impact on the image quality and healing potential of a Study Burn
  • Any condition that, in the opinion of the Investigator, may prevent compliance with the study requirements or compromise Participant safety
  • Participants without a burn on the hands, feet, head or neck, or burns located on these regions only on the palmar or plantar surfaces
  • Chemical or any other non-thermal burns
  • 8. Participants anticipated to or undergoing enzymatic debridemen9

结局指标

主要结局

Label Expansion Through Imaging HHF

时间窗: Time of Injury through 21 Day Healing Assessment

The number of Hand, Head, Feet (HHF) images collected with the DeepView AI System (DV) is the primary objective of this study in order to support the expansion of the intended use of the DV System. These images are used to assess the ground truth using a panel of expert burn surgeons.

次要结局

未报告次要终点

研究者

发起方
SpectralMD
申办方类型
Industry
责任方
Sponsor

相似试验